Craneware (LON:CRW) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

Craneware plc (LON:CRW)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,966.26 ($26.17) and traded as low as GBX 1,920 ($25.55). Craneware shares last traded at GBX 1,940 ($25.82), with a volume of 28,233 shares changing hands.

Analyst Upgrades and Downgrades

CRW has been the topic of several research analyst reports. Shore Capital reaffirmed a “buy” rating on shares of Craneware in a report on Thursday, May 8th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 2,800 ($37.26) price target on shares of Craneware in a report on Tuesday, March 11th.

Craneware Price Performance

The business’s 50 day moving average is GBX 1,725.10 and its two-hundred day moving average is GBX 1,966.08. The firm has a market capitalization of £825.30 million, a PE ratio of 70.97 and a beta of 0.28. The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00.

Craneware Cuts Dividend

The business also recently announced a dividend, which was paid on Thursday, April 17th. Investors of record on Thursday, March 20th were paid a GBX 13.50 ($0.18) dividend. This represents a yield of 0.71%. The ex-dividend date of this dividend was Thursday, March 20th. Craneware’s dividend payout ratio is currently 107.14%.

Insider Activity at Craneware

In related news, insider Will Whitehorn bought 1,911 shares of the stock in a transaction that occurred on Thursday, April 24th. The shares were acquired at an average cost of GBX 1,584 ($21.08) per share, with a total value of £30,270.24 ($40,285.12). 19.28% of the stock is currently owned by insiders.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.